Chemoinformaics analysis of methyl-2-butyric acid
| Molecular Weight | 102.133 | nRot | 2 |
| Heavy Atom Molecular Weight | 92.053 | nRig | 1 |
| Exact Molecular Weight | 102.068 | nRing | 0 |
| Solubility: LogS | -0.35 | nHRing | 0 |
| Solubility: LogP | 1.269 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 16.6219 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.567 |
| Synth | 2.51 |
| Natural Product Likeliness | 1.055 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.007 |
| CACO-2 | -4.65 |
| MDCK | 0.0000995 |
| BBB | 0.971 |
| PPB | 0.431496 |
| VDSS | 0.37 |
| FU | 0.523923 |
| CYP1A2-inh | 0.026 |
| CYP1A2-sub | 0.33 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.278 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.814 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.069 |
| CL | 6.575 |
| T12 | 0.81 |
| hERG | 0.008 |
| Ames | 0.006 |
| ROA | 0.199 |
| SkinSen | 0.179 |
| Carcinogencity | 0.047 |
| EI | 0.994 |
| Respiratory | 0.199 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.942276 |